Stock Earnings

Question 1

What are AstraZeneca PLC's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), AstraZeneca PLC has a total asset of $104,035, Net profit of $7,035

Question 2

What are the key financial ratios for AZN?

Accepted Answer

AstraZeneca PLC's Current ratio is 1.64, has a Net margin is 13.01, sales per share of $34.59.

Question 3

How is AstraZeneca PLC's revenue broken down by segment or geography?

Accepted Answer

AstraZeneca PLC largest revenue segment is Other, at a revenue of -4,002,000,000 in the most earnings release.For geography, UK Revenue is the primary market for AstraZeneca PLC, at a revenue of 4,740,000,000.

Question 4

Is AstraZeneca PLC profitable?

Accepted Answer

yes, according to the latest financial statements, AstraZeneca PLC has a net profit of $7,035

Question 5

Does AstraZeneca PLC have any liabilities?

Accepted Answer

yes, AstraZeneca PLC has liability of 63,249

Question 6

How many outstanding shares for AstraZeneca PLC?

Accepted Answer

AstraZeneca PLC has a total outstanding shares of 1,550.54

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	58,127	54,073	45,811	44,351	37,417	26,617
Revenue Growth (YoY)	14%	18%	3%	19%	41%	9%
Cost of Revenue	10,523	9,658	8,068	8,649	9,542	5,270
Gross Profit	47,604	44,415	37,743	35,702	27,875	21,347
Selling, General & Admin	15,837	15,495	14,649	13,512	11,519	9,338
Research & Development	13,664	12,211	10,271	9,612	8,519	6,094
Operating Expenses	33,454	31,732	28,827	26,874	22,973	16,948
Other Non Operating Income (Expenses)	--	-291	-457	-441	-502	-530
Pretax Income	11,439	8,691	6,899	2,501	-265	3,916
Income Tax Expense	2,035	1,650	938	-792	-380	772
Net Income	9,399	7,035	5,955	3,288	112	3,196
Net Income Growth	45%	18%	81%	2,836%	-97%	139%
Shares Outstanding (Diluted)	1,561	1,563	1,562	1,560	1,427	1,313
Shares Change (YoY)	0%	0%	0%	9%	9%	1%
EPS (Diluted)	6.02	4.5	3.81	2.11	0.08	2.43
EPS Growth	45%	18%	81%	2,538%	-97%	136%
Free Cash Flow	9,567	7,275	6,567	7,237	3,763	2,193
Free Cash Flow Per Share	6.12	4.65	4.2	4.63	2.63	1.67
Gross Margin	81.89%	82.13%	82.38%	80.49%	74.49%	80.2%
Operating Margin	24.34%	23.45%	19.46%	19.9%	13.1%	16.52%
Profit Margin	16.16%	13.01%	12.99%	7.41%	0.29%	12%
Free Cash Flow Margin	16.45%	13.45%	14.33%	16.31%	10.05%	8.23%
EBITDA	20,709	19,371	14,303	14,308	11,432	7,548
EBITDA Margin	35.62%	35.82%	31.22%	32.26%	30.55%	28.35%
D&A For EBITDA	6,559	6,688	5,387	5,480	6,530	3,149
EBIT	14,150	12,683	8,916	8,828	4,902	4,399
EBIT Margin	24.34%	23.45%	19.46%	19.9%	13.1%	16.52%
Effective Tax Rate	17.79%	18.98%	13.59%	-31.66%	143.39%	19.71%

AstraZeneca PLC (AZN) Price

AZN Stock Price Chart

AZN Income

Follow-Up Questions